stockportfolio.pro
AdaptHealth Corp. (AHCO)
Healthcare · Medical Devices · NasdaqCM
AdaptHealth Corp. revenue & earnings — last 8 fiscal years
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $345.28M | $529.64M | $1.06B | $2.45B | $2.97B | $3.20B | $3.26B | $3.24B |
| Gross profit | $51.89M | $88.94M | $157.79M | $445.61M | $580.12M | $624.07M | $681.09M | $609.20M |
| Net income | $23.26M | $-21.34M | $-161.63M | $156.18M | $69.32M | $-678.89M | $90.42M | $-70.79M |
| Net margin | 6.7% | -4.0% | -15.3% | 6.4% | 2.3% | -21.2% | 2.8% | -2.2% |
Source: AdaptHealth Corp. SEC filings (10-K).
What growth is priced into AHCO stock?
At today's market cap of $1.36B, AdaptHealth Corp. is priced for free-cash-flow growth of about -8.9% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $219.38M from the FY ending 2025-12-31). For comparison, free cash flow actually grew 7.1%/yr over the last five fiscal years and revenue 25.2%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 8 years of AdaptHealth Corp. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track AHCO in your portfolio →
AdaptHealth Corp. financial history by metric
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
AdaptHealth Corp. — frequently asked questions
What is AdaptHealth Corp.'s revenue?
AdaptHealth Corp. (AHCO) reported revenue of $3.24B for fiscal year 2025, down 0.5% from the prior year, according to its SEC filings.
Is AdaptHealth Corp. profitable?
No — AHCO reported a net loss of $-70.79M in fiscal 2025.
What is AHCO's P/E ratio?
AdaptHealth Corp. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is AdaptHealth Corp. growing?
AHCO's revenue grew at roughly 25.2% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does AdaptHealth Corp. have?
As of fiscal year 2025, AHCO carried roughly $1.74B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is AdaptHealth Corp.'s gross margin?
AHCO's gross margin was 18.8% in fiscal 2025 — gross profit of $609.20M on revenue of $3.24B.
What is AdaptHealth Corp.'s market cap?
AdaptHealth Corp. (AHCO) has a market capitalization of about $1.36B, based on the latest data in our nightly-refreshed cache.
When does AdaptHealth Corp.'s fiscal year end?
AHCO's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into AHCO stock?
At today's market cap of $1.36B, AdaptHealth Corp. is priced for free-cash-flow growth of about -8.9% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $219.38M from the FY ending 2025-12-31). For comparison, free cash flow actually grew 7.1%/yr over the last five fiscal years and revenue 25.2%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from AdaptHealth Corp.'s official SEC filings (10-K and 10-Q), covering 8 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.